首頁 > 市場調查報告書 > 醫療設備

麻醉

市場調查報告書

商品編碼

1541645

2024-2032 年吸入麻醉市場報告（按產品（地氟烷、七氟烷、異氟烷等）、應用（誘導、維持）、最終用戶（醫院、門診手術中心等）和地區

Inhalation Anesthesia Market Report by Product (Desflurane, Sevoflurane, Isoflurane, and Others), Application (Induction, Maintenance), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032

出版日期: 2024年08月10日 | 出版商:

IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年全球吸入麻醉市場規模達16.0億美元。慢性疾病的盛行率日益上升，製藥公司、醫療器材製造商和醫療機構之間的合作，以及政府和私人醫療保健提供者對最先進設備的投資不斷增加是推動市場的一些主要因素。

吸入麻醉市場分析：

市場成長與規模：市場正在穩步成長，這可歸因於全球外科手術的增加和醫療保健基礎設施的進步。此外，各種外科手術對麻醉的需求不斷成長正在推動吸入麻醉市場的成長。

主要市場促進因素：慢性病盛行率不斷上升、老年人口不斷增加以及人們對手術中吸入麻醉益處的認知不斷提高是推動市場的一些關鍵因素。此外，麻醉輸送系統的技術進步和新麻醉劑的推出正在刺激市場成長。

主要市場趨勢：吸入麻醉產業趨勢包括，由於吸入麻醉具有起效快、給藥方便、恢復快速等優點，門診手術中心擴大採用吸入麻醉。此外，人們正在轉向開發環保麻醉劑和輸送系統，以盡量減少對環境的影響。

地理趨勢：北美因其完善的醫療基礎設施、高手術率以及強勁的研發 (R&D) 活動而引領市場。然而，在醫療支出增加、醫療設施改善和龐大患者群體的推動下，亞太地區正在成為一個快速成長的市場。

競爭格局：市場的特徵是主要參與者之間競爭激烈。他們專注於策略性舉措，例如併購 (M&A)、產品發布和合作，以加強其市場地位並擴大其產品組合。

挑戰與機會：雖然市場面臨挑戰，例如管理麻醉藥物和設備的核准和商業化的嚴格監管框架，但由於對微創（MI）手術和正在進行的研究活動的需求不斷增加，新興市場也遇到了機會新型麻醉劑及給藥方法。

吸入麻醉市場趨勢：

麻醉劑和輸送系統的不斷進步

製藥公司和醫療設備製造商正在大力投資研發，以創造更有效、更安全的麻醉氣體和蒸氣。這些創新旨在透過降低不良反應的風險和改善整體麻醉體驗來提高患者的治療效果。正在開發具有改進的藥物動力學特徵的新型藥物，能夠更快地誘導和甦醒，從而縮短患者在手術室的時間。此外，複雜的輸送系統（包括精確的蒸發器和監控技術）的開發可確保麻醉劑的準確給藥和滴定，最大限度地減少劑量過量或不足的可能性。這些進步不僅有助於更好的患者護理，還吸引醫療保健提供者採用這些現代解決方案，從而促進吸入麻醉市場的成長。

手術數量和患者數量不斷增加

人口成長通常伴隨著人口老化，與外科手術需求的增加直接相關。由於與年齡相關的疾病，例如心血管疾病、關節置換和癌症治療，老年人口往往需要更多的醫療干預。因此，骨科、心臟病學、腫瘤學和一般外科等外科專業的需求增加。由於起效快且鎮靜深度可控，吸入麻醉被證明是這些手術的首選。它在確保患者失去知覺和維持其生理穩定性之間提供了平衡。此外，醫學知識和技術的擴展拓寬了可行手術介入的範圍。微創手術、機器人輔助手術和其他創新技術的出現，使得介入措施更加安全快速。

擴建門診手術中心

ASC 具有許多優勢，例如成本效益、縮短患者住院時間以及降低院內感染的風險。吸入麻醉起效快、恢復快，非常符合 ASC 的要求。在 ASC 接受手術的患者通常更喜歡吸入麻醉，因為這樣可以讓他們更快恢復日常活動。此外，吸入麻醉能夠最大限度地減少術後噁心和嘔吐，這在門診環境中特別有價值。隨著ASC數量的成長以滿足門診手術不斷成長的需求，吸入麻醉的需求預計將大幅增加。這一趨勢也鼓勵製造商開發更便攜、更方便用戶使用的麻醉輸送系統，以滿足 ASC 的獨特需求。

The global inhalation anesthesia market size reached US$ 1.60 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.16 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032. The increasing prevalence of chronic medical disorders, collaborations between pharmaceutical companies, medical device manufacturers, and healthcare institutions, and the rising investments by governments and private healthcare providers in state-of-the-art equipment are some of the major factors propelling the market.

Inhalation Anesthesia Market Analysis:

Market Growth and Size: The market is witnessing steady growth, which can be attributed to increasing surgical procedures worldwide and advancements in healthcare infrastructure. In addition, the rising demand for anesthesia in various surgical procedures is propelling the inhalation anesthesia market growth.

Major Market Drivers: The growing prevalence of chronic diseases, expanding geriatric population, and rising awareness about the benefits of inhalation anesthesia in surgeries are some of the key factors driving the market. Additionally, technological advancements in anesthesia delivery systems and the introduction of new anesthetic agents are stimulating the market growth.

Key Market Trends: Inhalation anesthesia Industry trends include the increasing adoption of inhalation anesthesia in ambulatory surgical centers due to its advantages, such as rapid onset, easy administration, and faster recovery. Moreover, there is a shift towards the development of eco-friendly anesthetic agents and delivery systems to minimize environmental impact.

Geographical Trends: North America leads the market owing to its well-established healthcare infrastructure, high surgical procedure rates, and robust research and development (R&D) activities. However, Asia Pacific is emerging as a fast-growing market, driven by rising healthcare expenditures, improving healthcare facilities, and a large patient pool.

Competitive Landscape: The market is characterized by intense competition among key players. They are focusing on strategic initiatives, such as mergers and acquisitions (M&A), product launches, and collaborations, to strengthen their market position and expand their product portfolios.

Challenges and Opportunities: While the market faces challenges, such as stringent regulatory framework governing the approval and commercialization of anesthesia drugs and devices, it also encounters opportunities in in emerging markets due to the increasing demand for minimally invasive (MI) surgeries and ongoing research activities on novel anesthetic agents and delivery methods.

Inhalation Anesthesia Market Trends:

Continual Advancements in Anesthetic Agents and Delivery Systems

Pharmaceutical companies and medical device manufacturers are heavily investing in research and development to create more effective and safer anesthetic gases and vapors. These innovations aim to enhance patient outcomes by reducing the risk of adverse effects and improving the overall anesthesia experience. Newer agents are being developed with improved pharmacokinetic profiles, enabling faster induction and emergence from anesthesia, thus shortening the time patients spend in the operating room. Furthermore, the development of sophisticated delivery systems, including precise vaporizers and monitoring technologies, ensures accurate administration and titration of anesthetic agents, minimizing the chances of over or under dosing. These advancements not only contribute to better patient care but also attract healthcare providers to adopt these modern solutions, thus catalyzing the growth of the inhalation anesthesia market.

Rising Surgical Procedures and Patient Volume

Population growth, often accompanied by an aging demographic, directly correlates with a heightened demand for surgical procedures. The elderly population tends to require more medical interventions due to age-related ailments, such as cardiovascular diseases, joint replacements, and cancer treatments. Consequently, surgical specialties such as orthopedics, cardiology, oncology, and general surgery have seen a rise in demand. Inhalation anesthesia proves to be a preferred option for these procedures due to its rapid onset and controllable depth of sedation. It offers a balance between ensuring patient's unconsciousness and maintaining their physiological stability. Furthermore, the expansion of medical knowledge and technology has broadened the spectrum of feasible surgical interventions. Minimally invasive procedures, robotics-assisted surgeries, and other innovative techniques have emerged, allowing for safer and quicker interventions.

Expansion of Ambulatory Surgical Centers

ASCs offer numerous advantages, such as cost-effectiveness, shorter patient stays, and reduced risk of hospital-acquired infections. Inhalation anesthesia aligns well with the requirements of ASCs due to its rapid onset and quick recovery profile. Patients undergoing procedures at ASCs often prefer inhalation anesthesia as it allows them to return to their daily activities more swiftly. Moreover, inhalation anesthesia's ability to minimize post-operative nausea and vomiting is particularly valuable in an outpatient setting. As the number of ASCs grows to accommodate the increasing demand for outpatient surgeries, the demand for inhalation anesthesia is expected to witness a significant rise. This trend also encourages manufacturers to develop more portable and user-friendly anesthesia delivery systems tailored to the unique needs of ASCs.

Inhalation Anesthesia Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global inhalation anesthesia market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Desflurane

Sevoflurane

Isoflurane

Others

Sevoflurane dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes desflurane, sevoflurane, isoflurane, and others. According to the report, sevoflurane represented the largest segment.

Sevoflurane's popularity is largely due to its favorable pharmacokinetic profile. With its rapid induction and emergence characteristics, sevoflurane enables anesthesiologists to guide patients swiftly and smoothly into and out of anesthesia. This not only enhances operational efficiency in medical settings but also ensures that patients experience minimal delay in the start and conclusion of surgical procedures. Moreover, sevoflurane's low blood-gas solubility allows for rapid equilibration between the lungs and the bloodstream, translating into quicker adjustments in the depth of anesthesia and the potential for faster recoveries. Sevoflurane's reduced likelihood of causing organ toxicity or compromising vital functions offers a degree of reassurance to both medical professionals and patients. This safety aspect has been pivotal in cementing sevoflurane's role as a cornerstone of inhalation anesthesia practice, particularly in paediatric and geriatric populations where safety is of paramount concern.

Breakup by Application:

Induction

Maintenance

Maintenance dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes induction and maintenance. According to the report, maintenance represented the largest segment.

The prominence of the maintenance phase is attributed to its role in ensuring patient comfort, surgical precision, and optimal outcomes. Once the patient is induced into anesthesia and the initial surgical incisions are made, maintaining the appropriate anesthetic depth becomes paramount. Anesthesia providers carefully titrate inhalation anesthetic agents to balance the patient's need for complete insensitivity to pain while avoiding over-sedation, which could lead to complications or lengthened recovery times. This dynamic balance requires continuous monitoring and adjustment throughout the procedure, highlighting the importance of skilled anesthesiologists. Moreover, the maintenance phase is directly linked to surgical efficacy and precision. Surgeons rely on patients being adequately anesthetized and immobilized to perform delicate procedures with accuracy. Any fluctuation in the anesthesia depth during the maintenance phase could lead to patient movement or awareness, potentially compromising the surgery's success.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals represented the largest segment.

Hospitals offer a diverse range of medical services, encompassing routine surgeries, emergency interventions, and specialized procedures across various medical specialties. The sheer volume and variety of surgical interventions conducted in hospitals create a substantial demand for anesthesia services, and inhalation anesthesia, with its ability to provide rapid induction and adjustable sedation levels, aligns seamlessly with the dynamic environment of hospital operating rooms. Additionally, hospitals provide a comprehensive infrastructure for anesthesia administration and patient care. They possess well-equipped operating suites, sophisticated monitoring systems, and experienced anesthesia teams capable of managing a wide spectrum of cases. This robust setup allows hospitals to efficiently manage the complexities associated with different surgeries, including those requiring inhalation anesthesia. Furthermore, the presence of specialized units within hospitals, such as pediatric and cardiac surgery departments, highlights the versatility of inhalation anesthesia across diverse patient populations and procedural requirements.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest inhalation anesthesia market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is characterized by its emphasis on medical advancements and innovation. The presence of renowned research institutions, academic medical centers, and cutting-edge pharmaceutical companies fosters an environment conducive to the development of new anesthetic agents, delivery methods, and monitoring technologies. This commitment to innovation not only enhances patient care but also attracts healthcare professionals to adopt state-of-the-art anesthesia practices, including inhalation anesthesia techniques. The region's regulatory landscape and adherence to stringent safety standards further contribute to its dominance. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) play a pivotal role in ensuring the safety and efficacy of anesthesia agents and equipment. This rigorous oversight augments the confidence of healthcare providers and patients in the use of inhalation anesthesia, solidifying North America's position as a leader in the field. Also, North America's focus on medical education and training ensures that anesthesia providers are well-equipped to administer inhalation anesthesia safely and efficiently.

Competitive Landscape:

Pharmaceutical and medical device companies are heavily investing in research and development to create advanced anesthetic agents, delivery systems, and monitoring technologies. Moroever, companies are frequently introducing new inhalation anesthesia products and equipment to cater to the evolving needs of healthcare providers and patients. These products often incorporate the latest technological advancements, such as more precise vaporizers, integrated monitoring systems, and user-friendly interfaces. Additionally, leading players are focusing on developing innovative technologies that enhance the administration and monitoring of inhalation anesthesia. This includes the integration of electronic medical records (EMR) systems, real-time data analysis, and remote monitoring capabilities to ensure optimal patient care and safety. Additionally, numerous companies are providing training and educational programs to healthcare professionals, including anesthesiologists, nurse anaesthetists, and operating room staff. These programs help ensure that healthcare providers are well-versed in the latest techniques, technologies, and safety measures related to inhalation anesthesia.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbvie Inc.

Baxter International Inc.

Fresenius SE & Co. KGaA

Halocarbon Products Corporation

Hikma Pharmaceuticals PLC

Lunan Pharmaceutical Group Co. Ltd

Merck KGaA

Piramal Enterprises Ltd.

Troikaa Pharmaceuticals Ltd.

Recent Developments:

In May 2023, Piramal Enterprises Ltd collaborated with plus therapeutics to meet increase in investigational drug demand for ongoing and planned clinical trials.

In April 2023, Baxter International Inc. launched Zosyn Premix. It is indicated for the treatment of multiple infections caused by susceptible bacteria.

In December 2021, Hikma Pharmaceuticals PLC launched Bupivacaine HCl Injection. Bupivacaine HCl Injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures.

Key Questions Answered in This Report

1. What was the size of the global inhalation anesthesia market in 2023?
2. What is the expected growth rate of the global inhalation anesthesia market during 2024-2032?
3. What are the key factors driving the global inhalation anesthesia market?
4. What has been the impact of COVID-19 on the global inhalation anesthesia market?
5. What is the breakup of the global inhalation anesthesia market based on the product?
6. What is the breakup of the global inhalation anesthesia market based on the application?
7. What is the breakup of the global inhalation anesthesia market based on the end user?
8. What are the key regions in the global inhalation anesthesia market?
9. Who are the key players/companies in the global inhalation anesthesia market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Inhalation Anesthesia Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Desflurane
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Sevoflurane
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Isoflurane
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Application

7.1 Induction
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Maintenance
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abbvie Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Baxter International Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Fresenius SE & Co. KGaA
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Halocarbon Products Corporation
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Hikma Pharmaceuticals PLC
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Lunan Pharmaceutical Group Co. Ltd
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Merck KGaA
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Piramal Enterprises Ltd.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
- 14.3.9 Troikaa Pharmaceuticals Ltd
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio

簡介目錄圖表

List of Figures

Figure 1: Global: Inhalation Anesthesia Market: Major Drivers and Challenges
Figure 2: Global: Inhalation Anesthesia Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Inhalation Anesthesia Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Inhalation Anesthesia Market: Breakup by Product (in %), 2023
Figure 5: Global: Inhalation Anesthesia Market: Breakup by Application (in %), 2023
Figure 6: Global: Inhalation Anesthesia Market: Breakup by End User (in %), 2023
Figure 7: Global: Inhalation Anesthesia Market: Breakup by Region (in %), 2023
Figure 8: Global: Inhalation Anesthesia (Desflurane) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Inhalation Anesthesia (Desflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Inhalation Anesthesia (Sevoflurane) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Inhalation Anesthesia (Sevoflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Inhalation Anesthesia (Isoflurane) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Inhalation Anesthesia (Isoflurane) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Inhalation Anesthesia (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Inhalation Anesthesia (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Inhalation Anesthesia (Induction) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Inhalation Anesthesia (Induction) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Inhalation Anesthesia (Maintenance) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Inhalation Anesthesia (Maintenance) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Inhalation Anesthesia (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Inhalation Anesthesia (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Inhalation Anesthesia (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Inhalation Anesthesia (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Inhalation Anesthesia (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: North America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: North America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: United States: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: United States: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Canada: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Canada: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Asia-Pacific: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Asia-Pacific: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: China: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: China: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Japan: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Japan: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: India: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: India: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: South Korea: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: South Korea: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Australia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Australia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Indonesia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Indonesia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Europe: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Europe: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Germany: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Germany: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: France: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: France: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: United Kingdom: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: United Kingdom: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Italy: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Italy: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Spain: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Spain: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Russia: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Russia: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Latin America: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Latin America: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Brazil: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Brazil: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Mexico: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Mexico: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Middle East and Africa: Inhalation Anesthesia Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Middle East and Africa: Inhalation Anesthesia Market: Breakup by Country (in %), 2023
Figure 74: Middle East and Africa: Inhalation Anesthesia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Global: Inhalation Anesthesia Industry: SWOT Analysis
Figure 76: Global: Inhalation Anesthesia Industry: Value Chain Analysis
Figure 77: Global: Inhalation Anesthesia Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Inhalation Anesthesia Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Inhalation Anesthesia Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Inhalation Anesthesia Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Inhalation Anesthesia Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Inhalation Anesthesia Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Inhalation Anesthesia Market: Competitive Structure
Table 7: Global: Inhalation Anesthesia Market: Key Players

02-2729-4219

+886-2-2729-4219